secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0001171843-24-002152
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nanophase reports record Q1 revenue $9.9M, net income $0.9M vs loss, BASF litigation resolved
--------------------------------------------------------------------------------

- Q1 revenue $9.9M (+4% YoY); net income $0.9M vs net loss of $1.2M in Q1 2023.
- Gross margin improved to 36% from 23% YoY; Solésence product revenue contributed $8.0M.
- BASF litigation amicably resolved; company expects breakout year with $40M+ in shipped/open orders.
- Three consecutive profitable months (Jan-Mar 2024); margin expansion due to improved product mix.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184324002152/0001171843-24-002152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184324002152/f8k_042324.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer